Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.42M Hold
4,050
0.1% 109
2025
Q4
$1.33M Sell
4,050
-450
-10% -$143K 0.08% 115
2025
Q3
$1.27M Hold
4,500
0.08% 103
2025
Q2
$1.26M Hold
4,500
0.09% 103
2025
Q1
$1.4M Hold
4,500
0.12% 89
2024
Q4
$1.17M Buy
+4,500
New +$1.34M 0.09% 98

Other funds holding AMGN

Triglav Skladi's AMGN Position: Q1 2026 in Review

Triglav Skladi held its Amgen (AMGN) position steady in Q1 2026 at 4,050 shares worth $1.42M. The position accounts for 0.1% of the portfolio, ranked #109.

Triglav Skladi first reported a position in AMGN in Q4 2024 and has held it in 6 quarters since. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Triglav Skladi held 4,050 shares of Amgen worth $1.42M as of Q1 2026.
  • Triglav Skladi left its Amgen share count unchanged in Q1 2026.
  • Amgen made up 0.1% of Triglav Skladi's portfolio in Q1 2026, its #109 holding.
  • Triglav Skladi first reported a position in Amgen in Q4 2024 and has held it in 6 quarters since.
  • 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Triglav Skladi's 13F filing for Q1 2026, filed 4 May 2026.